Back to BlackRock, Inc.

VRTX
6 quarters

Position history for BlackRock, Inc.'s holdings in VERTEX PHARMACEUTICALS INC

BlackRock, Inc. holds 24M shares of VRTX (VERTEX PHARMACEUTICALS INC), worth $10.7B as of 2026-Q1. The position was increased (+0.9% shares). VRTX represents 0.2% of BlackRock, Inc.'s portfolio.

Current Value

$10.7B

Current Shares

24M

Total Value Change

+$1.9B

Total Shares Change

+2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
24M
+0.9%
$10.7B0.2%$474.27
38
2025-Q4
Increased
23.8M
+6.7%
$10.8B0.2%$453.74
41
2025-Q3
Increased
22.3M
+1.7%
$8.7B0.2%$395.31
39
2025-Q2
Increased
21.9M
+0.4%
$9.7B0.2%$441.30
38
2025-Q1
Decreased
21.8M
-0.2%
$10.6B0.2%$492.69
0
2024-Q4
New
21.8M
-
$8.8B0.2%$399.35
53

Other major holders of VRTX: Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used